|
Category Archives: AZBio News
Pursing the Possible – Stephen Albert Johnston’s work featured on CNN
Is it possible to create a general cancer vaccine? Stephen Albert Johnston may find the answer with the help of man’s best friend.
Application Process Opens for New Life Science Incubator in Oro Valley
OVIL, the Oro Valley Innovation Lab, is now accepting applications for laboratory/office space before the facility opens in the spring of 2020. Continue reading
TGen Study: Individuals with Elevated Risk of Alzheimer’s Ma Show Memory Changes up to Four Decades before Typical Age of Onset
Lack of cure for dementia highlights need for early detection; early interventionContinue reading
Cancer Prevention Pharmaceuticals (CPP) Reports FAP Phase 3 Clinical Trial Results at Digestive Disease Week Conference
Based on unmet medical need and encouraging data company will explore regulatory pathwaysContinue reading
UA Researcher Studying New Treatment to Prolong Survival in Advanced Biliary Tract Cancers
Dr. Rachna Shroff is seeking a “goldmine of information” in her quest to extend survival and improve quality of life for patients with cancers of the liver, gallbladder and pancreas.Continue reading
Two Arizona companies partner to democratize access to healthcare
ReDirect Health and AdviNOW Medical announced today that they have created a strategic partnership to deliver affordable, high-quality primary care to low-and-middle income populations using artificial intelligence (AI), Augmented Reality (AR), automated patient engagement and data analytics to improve efficiency and outcomes.Continue reading
Protect Medical Innovation Act of 2019 Receives Strong Arizona Support
The Protect Medical Innovation Act of 2019 ( HR 2207 and S. 692) would permanently repeal the Medical Device Excise Tax. The 2.3% levy on U.S. medical device sales went into effect in 2013 but was only in place for two years before Congress put a moratorium in place. When that ended in January 2018, a second moratorium was enacted that’s due to expire at the end of this year. Continue reading
IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products